AL
SYK icon

Aspiriant LLC’s Stryker SYK Stock Holding History

Aspiriant LLC’s Portfolio SYK Stock Details SYK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,246
Closed -$449K – 303
2024
Q4 		$449K Buy
1,246
+50
+4% +$18.5K 0.02% 198
2024
Q3 		$432K Buy
1,196
+40
+3% +$13.8K 0.02% 199
2024
Q2 		$393K Sell
1,156
-114
-9% -$38.6K 0.02% 201
2024
Q1 		$455K Sell
1,270
-20
-2% -$6.73K 0.02% 207
2023
Q4 		$386K Buy
1,290
+353
+38% +$99.1K 0.02% 216
2023
Q3 		$256K Buy
937
+64
+7% +$18.4K 0.01% 242
2023
Q2 		$266K Hold
873
– – 0.01% 241
2023
Q1 		$249K Hold
873
– – 0.01% 241
2022
Q4 		$214K Buy
+873
New +$198K 0.01% 252

Other funds holding SYK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GT
Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Aspiriant LLC's SYK Position: Q1 2025 in Review

Aspiriant LLC sold out of Stryker (SYK) in Q1 2025, closing a stake of 1,246 shares — an estimated $449K sold.

Aspiriant LLC first reported a position in SYK in Q4 2022 and held it in 9 quarters. The position peaked at $455K in Q1 2024. 2,230 funds tracked by Wall St. Rank hold SYK as of Q1 2025.

  • Aspiriant LLC reported no remaining Stryker position as of Q1 2025 after selling out during the quarter.
  • Aspiriant LLC sold 1,246 Stryker shares in Q1 2025, an estimated $449K.
  • Aspiriant LLC first reported a position in Stryker in Q4 2022 and held it in 9 quarters.
  • Aspiriant LLC's Stryker position peaked at $455K in Q1 2024.
  • 2,230 funds tracked by Wall St. Rank held Stryker as of Q1 2025.

Based on Aspiriant LLC's 13F filing for Q1 2025, filed 21 Apr 2025.